New antibody therapy targets Hard-to-Treat cancers in early trial
NCT ID NCT06005493
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 25 times
Summary
This study tests an experimental drug called AZD5863 in adults with advanced stomach, esophageal, or pancreatic cancers that have spread. The drug is designed to help the body's immune cells attack cancer cells. The main goals are to check safety and see if the drug can shrink tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGJacksonville, Florida, 32224, United States
-
Research Site
RECRUITINGRochester, Minnesota, 55905, United States
-
Research Site
WITHDRAWNNew York, New York, 10065, United States
-
Research Site
RECRUITINGBeijing, 100142, China
-
Research Site
RECRUITINGBeijing, 101199, China
-
Research Site
RECRUITINGShandong, China
-
Research Site
RECRUITINGToulouse, 31059, France
-
Research Site
RECRUITINGVillejuif, 94805, France
-
Research Site
RECRUITINGChūōku, 104-0045, Japan
-
Research Site
RECRUITINGKashiwa, 227-8577, Japan
-
Research Site
RECRUITINGKōtoku, 135-8550, Japan
-
Research Site
RECRUITINGAmsterdam, 1081 HV, Netherlands
-
Research Site
RECRUITINGGroningen, 9713 GZ, Netherlands
-
Research Site
RECRUITINGRotterdam, 3015 GD, Netherlands
-
Research Site
RECRUITINGSeoul, 03080, South Korea
-
Research Site
RECRUITINGSeoul, 03722, South Korea
-
Research Site
RECRUITINGSeoul, 05505, South Korea
-
Research Site
RECRUITINGSeoul, 06351, South Korea
-
Research Site
RECRUITINGKaohsiung City, 80756, Taiwan
-
Research Site
RECRUITINGTainan, 70403, Taiwan
-
Research Site
RECRUITINGTaoyuan, 00333, Taiwan
-
Research Site
RECRUITINGDundee, DD1 9SY, United Kingdom
-
Research Site
RECRUITINGLondon, E1 1BB, United Kingdom
-
Research Site
RECRUITINGMetropolitan Borough of Wirral, CH63 4JY, United Kingdom
-
Research Site
RECRUITINGOxford, OX3 7LE, United Kingdom
Conditions
Explore the condition pages connected to this study.